外周血干细胞联合富血小板血浆在组织修复中的研究进展

胡家琨 ,  黄象艳

中国输血杂志 ›› 2026, Vol. 39 ›› Issue (6) : 818 -826.

PDF (1250KB)
中国输血杂志 ›› 2026, Vol. 39 ›› Issue (6) : 818 -826. DOI: 10.13303/j.cjbt.issn.1004-549x.2026.06.017
综述

外周血干细胞联合富血小板血浆在组织修复中的研究进展

作者信息 +

Progress in the application of peripheral blood stem cells combined with platelet-rich plasma in tissue repair

Author information +
文章历史 +
PDF (1279K)

摘要

随着再生医学的发展,外周血干细胞(peripheral blood stem cell,PBSC)与富血小板血浆(platelet-rich plasma,PRP)作为细胞治疗与生长因子疗法的代表,在组织工程与临床修复领域中展现出巨大的应用潜力。 PBSC 具有多向分化潜能、强大的旁分泌功能及归巢能力,而 PRP 则含多种生长因子,可诱导细胞增殖与分化、促进基质形成及抑制细胞凋亡。 二者联合应用已在骨、软骨、肌腱、皮肤及神经等多种组织修复中展现出显著的协同效应,这一效应主要通过以下机制协同推动组织再生进程:调控局部炎症反应、促进细胞迁移与分化,以及增强细胞外基质的重建。 然而,目前该联合疗法面临采集制备标准缺失、深层分子机制研究不足、高质量临床证据匮乏及监管与成本控制等挑战。 未来应着重加强机制研究与临床试验,推动制备工艺标准化与治疗策略个体化,从而促进两者向临床常规治疗转化。

Abstract

With the advancement of regenerative medicine, peripheral blood stem cells (PBSC) and platelet-rich plasma (PRP), as representatives of cell-based therapies and growth factor-based therapies, respectively, have demonstrated significant application potential in tissue engineering and clinical repair. PBSCs possess multilineage differentiation potential, robust paracrine function, and homing capacity, while PRP contains a variety of growth factors that can induce cell proliferation and differentiation, promote extracellular matrix formation, and inhibit apoptosis. The combination of the two has shown notable synergistic effects in the repair of various tissues, including bone, cartilage, tendon, skin, and nerve. This synergy primarily drives tissue regeneration through the following mechanisms:modulation of local inflammatory responses, promotion of cell migration and differentiation, and enhancement of extracellular matrix remodeling. However, this combined therapy currently faces challenges such as a lack of standardized collection and preparation protocols, insufficient investigation into the underlying molecular mechanisms, a paucity of high-quality clinical evidence, as well as regulatory and cost-control issues. Future efforts should focus on strengthening mechanistic research and clinical trials, advancing the standardization of preparation processes, and promoting individualized treatment strategies to facilitate its translation into routine clinical practice.

关键词

外周血干细胞 / 富血小板血浆 / 组织修复 / 再生医学 / 细胞治疗 / 协同作用

Key words

peripheral blood stem cells / platelet-rich plasma / tissue repair / regenerative medicine / cell therapy / synergistic effect

引用本文

引用格式 ▾
胡家琨,黄象艳. 外周血干细胞联合富血小板血浆在组织修复中的研究进展[J]. 中国输血杂志, 2026, 39(6): 818-826 DOI:10.13303/j.cjbt.issn.1004-549x.2026.06.017

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

JÄRBRINK K, NI G, SÖNNERGREN H. The humanistic and economic burden of chronic wounds:a protocol for a systematic review[J].Syst Rev, 2017, 6(1):15.

[2]

HENRY S, MAPULA S, GREVIOUS M. Maximizing wound coverage in full-thickness skin defects:A randomized-controlled trial of autologous skin cell suspension and widely meshed autograft versus standard autografting[J].J Trauma Acute Care Surg, 2024, 96(1):85-93.

[3]

HUELSBOEMER L, KNOEDLER L, KOCHEN A. Cellular therapeutics and immunotherapies in wound healing -on the pulse of time?[J].Mil Med Res, 2024, 11(1):23.

[4]

MULLIN J A, RAHMANI E, KIICK K L. Growth factors and growth factor gene therapies for treating chronic wounds[J].Bioeng Transl Med, 2024, 9(3):e10642.

[5]

JO T, ARAI Y, KONDO T . Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients[J].Cytotherapy, 2022, 24 (10): 1013-1025.

[6]

SUTHAR M, GUPTA S, BUKHARI S. Treatment of chronic non-healing ulcers using autologous platelet rich plasma:a case series[J].J Biomed Sci, 2017, 24(1):16.

[7]

ZHU Y, FU W. Peripheral blood-derived stem cells for the treatment of cartilage injuries: a systematic review[J].Front Bioeng Biotechnol, 2022, 10:956614.

[8]

HOPMAN R K, DIPERSIO J F. Advances in stem cell mobilization[J].Blood Rev, 2014, 28(1):31-40.

[9]

LéVESQUE J P, HENDY J, TAKAMATSU Y. Disruption of the CXCR4/ CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide[J].J Clin Invest, 2003, 111(2):187-196.

[10]

PETIT I, SZYPER-KRAVITZ M, NAGLER A. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4[J].Nat Immunol, 2002, 3(7):687-694.

[11]

LUO C, WANG L, WU G. Comparison of the efficacy of hematopoietic stem cell mobilization regimens:a systematic review and network meta-analysis of preclinical studies[J].Stem Cell Res Ther, 2021, 12(1):310.

[12]

CREES Z D, RETTIG M P, JAYASINGHE R G. Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma:a randomized phase 3 trial[J].Nat Med, 2023, 29(4):869-879.

[13]

CHEN Z, REN X, REN R. The combination of G-CSF and AMD3100 mobilizes bone marrow-derived stem cells to protect against cisplatin-induced acute kidney injury in mice[J].Stem Cell Res Ther, 2021, 12(1):209.

[14]

SCHROEDER M A, RETTIG M P, LOPEZ S. Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft[J]. Blood, 2017, 129(19):2680-2692.

[15]

CREES Z D, RETTIG M P, BASHEY A. Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor[J].Blood Adv, 2023, 7(18):5210-5214.

[16]

KARPOVA D, RETTIG M P, RITCHEY J. Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells[J].J Clin Invest, 2019, 129(7):2745-2759.

[17]

WADLEY A J, PRADANA F, NIJJAR T. Intra-apheresis cycling to improve the clinical efficacy of peripheral blood stem cell donations[J].Sports Med, 2025, 55(5):1085-1096.

[18]

KIM D H, SEO Y K, THAMBI T. Enhancing neurogenesis and angiogenesis with target delivery of stromal cell derived factor-1α using a dual ionic pH-sensitive copolymer[J].Biomaterials, 2015, 61:115-125.

[19]

CHEN P, TAO J, ZHU S. Radially oriented collagen scaffold with SDF-1 promotes osteochondral repair by facilitating cell homing[J].Biomaterials, 2015, 39:114-123.

[20]

WU M, MI J, QU G X. Role of hedgehog signaling pathways in multipotent mesenchymal stem cells differentiation[J]. Cell Transplant, 2024, 33:9636897241244943.

[21]

WATT S M,GULLO F,VAN DER GARDE M. The angiogenic properties of mesenchymal stem/ stromal cells and their therapeutic potential[J].Br Med Bull, 2013, 108(1):25-53.

[22]

SUROWIECKA A, CHRAPUSTA A, KLIMECZEK-CHRAPUSTA M. Mesenchymal stem cells in burn wound management[J].Int J Mol Sci, 2022, 23(23):15339.

[23]

ZHANG W, ZHAO L, CUI J. Wharton′s jelly-derived mesenchymal stem cells ameliorate high altitude-induced heart injury by promoting type 2 macrophage polarization via COX2-PGE2 pathway[J].Front Immunol, 2025, 16:1538046.

[24]

LIU F, QIU H, XUE M. MSC-secreted TGF-β regulates lipopolysaccharide-stimulated macrophage M2-like polarization via the Akt/ FoxO1 pathway[J].Stem Cell Res Ther, 2019, 10(1):345.

[25]

WANG Y, XIAO Y, YANG X. Bone marrow mesenchymal stem cells overexpressing stromal cell-derived factor 1 aid in bone formation in osteoporotic mice[J].BMC Musculoskelet Disord, 2024, 25(1):878.

[26]

ZHOU C,ZHANG B,YANG Y. Stem cell-derived exosomes: emerging therapeutic opportunities for wound healing[J].Stem Cell Res Ther, 2023, 14(1):107.

[27]

DAYAN V, YANNARELLI G, BILLIA F. Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/ macrophages after acute myocardial infarction[J].Basic Res Cardiol, 2011, 106(6):1299-1310.

[28]

ZARIPOVA L N,MIDGLEY A,CHRISTMAS S E. Mesenchymal stem cells in the pathogenesis and therapy of autoimmune and autoinflammatory diseases[J].Int J Mol Sci, 2023, 24(22):16040.

[29]

HASSANPOUR M,SALYBEKOV A A,KOBAYASHI S. CD34 positive cells as endothelial progenitor cells in biology and medicine[J].Front Cell Dev Biol, 2023, 11:1128134.

[30]

PAICHITROJJANA A, PAICHITROJJANA A. Platelet rich plasma and its use in hair regrowth:a review[J].Drug Des Devel Ther, 2022, 16:635-645.

[31]

CAVALLO C,ROFFI A, GRIGOLO B. Platelet-rich plasma:the choice of activation method affects the release of bioactive molecules[J].BioMed Res Int, 2016, 2016:6591717.

[32]

EVERTS P,ONISHI K,JAYARAM P. Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020[J].Int J Mol Sci, 2020, 21(20):7794.

[33]

LIU X,WANG L,MA C. Exosomes derived from platelet-rich plasma present a novel potential in alleviating knee osteoarthritis by promoting proliferation and inhibiting apoptosis of chondrocyte via Wnt/ β-catenin signaling pathway[J].J Orthop Surg Res, 2019, 14(1):470.

[34]

SHAO S, PAN R, CHEN Y. Autologous platelet-rich plasma for diabetic foot ulcer[J].Trends Endocrinol Metab, 2020, 31(12):885-890.

[35]

ALVES R,GRIMALT R . A review of platelet-rich plasma:history, biology, mechanism of action, and classification[J].Skin Appendage Disord, 2018, 4(1):18-24.

[36]

单桂秋,施琳颖,李艳辉,等. 自体富血小板血浆制备技术专家共识[J].中国输血杂志, 2021, 34(7):677-683.

[37]

SHAN G Q, SHI L Y, LI Y H, et al. Expert consensus on preparatiopn technique of autologous platelet-rich plasma[J].Chin J Blood Transfusion, 2021, 34 (7):677-683.

[38]

GOLDBERG S R, DIEGELMANN R F. Wound healing primer[J].Surg Clin North Am, 2010, 90(6):1133-1146.

[39]

XU J,CHEN X,ZHANG H. Platelet-rich plasma relieves inflammation and pain by regulating M1/ M2 macrophage polarization in knee osteoarthritis rats[J].Sci Rep, 2025, 15(1):12805.

[40]

SETHI D,MARTIN K E,SHROTRIYA S. Systematic literature review evaluating evidence and mechanisms of action for platelet-rich plasma as an antibacterial agent[J].J Cardiothorac Surg, 2021, 16(1):277.

[41]

LI W, ENOMOTO M, UKEGAWA M. Subcutaneous injections of platelet-rich plasma into skin flaps modulate proangiogenic gene expression and improve survival rates[J].Plast Reconstr Surg, 2012, 129(4):858-866.

[42]

ALTIERI A,VISSER G V,BUECHLER M B. Enter the matrix:fibroblast-immune cell interactions shape extracellular matrix deposition in health and disease[J].F1000Res, 2024, 13:119.

[43]

KOBAYASHI Y, SAITA Y, TAKAKU T. Platelet-rich plasma (PRP) accelerates murine patellar tendon healing through enhancement of angiogenesis and collagen synthesis[J].J Exp Orthop, 2020, 7(1):49.

[44]

ZHANG Y,WANG Z,ZONG C. Platelet-rich plasma attenuates the severity of joint capsule fibrosis following post-traumatic joint contracture in rats[J].Front Bioeng Biotechnol, 2022, 10:1078527.

[45]

LEE M J, KIM S H,SHIN S. Platelet-rich plasma enhances local homing of umbilical cord-derived mesenchymal stem cells to articular cartilage by increasing the quantity and activation of integrin β1[J].Stem Cell Res Ther, 2025, 16(1):487.

[46]

ABUAF O K,YILDIZ H, BALOGLU H . Histologic evidence of new collagen formulation using platelet rich plasma in skin rejuvenation:a prospective controlled clinical study[J].Ann Dermatol, 2016, 28(6):718-724.

[47]

LAI F, KAKUDO N, MORIMOTO N. Platelet-rich plasma enhances the proliferation of human adipose stem cells through multiple signaling pathways[J].Stem Cell Res Ther, 2018, 9(1):107.

[48]

CHEN H, LI G, LIU Y. Pleiotropic oles of CXCR4 in wound repair and regeneration[J]. Front Immunol, 2021, 12:668758.

[49]

CHU Q,JIANG X,XIAO Y. Rebuilding the myocardial microenvironment to enhance mesenchymal stem cells-mediated regeneration in ischemic heart disease[J].Front Bioeng Biotechnol, 2024, 12:1468833.

[50]

AL-SOWAYAN B,KEOGH R J,ABUMAREE M . Valproic acid stimulates in vitro migration of the placenta-derived mesenchymal stem/ stromal cell line CMSC29[J].Stem Cell Investig, 2019, 6:3.

[51]

GARG P, MAZUR M M,BUCK A C. Prospective review of mesenchymal stem cells differentiation into osteoblasts[J].Orthop Surg, 2017, 9(1):13-19.

[52]

MONCKEBERG J E,RAFOLS C,APABLAZA F . Intra-articular administration of peripheral blood stem cells with platelet-rich plasma regenerated articular cartilage and improved clinical outcomes for knee chondral lesions[J].Knee, 2019, 26(4):824-831.

[53]

ULLAH I, ABU-DAWUD R,BUSCH J F . VEGF-Supplemented extracellular matrix is sufficient to induce endothelial differentiation of human iPSC[J].Biomaterials, 2019, 216:119283.

[54]

LI L, LIU H,XU C. VEGF promotes endothelial progenitor cell differentiation and vascular repair through connexin 43[J].Stem Cell Res Ther, 2017, 8(1):237.

[55]

WU L W, CHEN W L, HUANG S M. Platelet-derived growth factor-AA is a substantial factor in the ability of adipose-derived stem cells and endothelial progenitor cells to enhance wound healing[J].FASEB J, 2019, 33(2):2388-2395.

[56]

TIAN D, LIU J, CHEN L. The protective effects of PI3K/ Akt pathway on human nucleus pulposus mesenchymal stem cells against hypoxia and nutrition deficiency[J].J Orthop Surg Res, 2020, 15(1):29.

[57]

FANG D, JIN P, HUANG Q. Platelet-rich plasma promotes the regeneration of cartilage engineered by mesenchymal stem cells and collagen hydrogel via the TGF-β/ SMAD signaling pathway[J].J Cell Physiol, 2019, 234(9):15627-15637.

[58]

YU J S,RAMASAMY T S,MURPHY N. PI3K/ mTORC2 regulates TGF-β/ Activin signalling by modulating Smad2/ 3 activity via linker phosphorylation[J].Nat Commun, 2015, 6:7212.

[59]

JIN Y, KATO T, FURU M. Mesenchymal stem cells cultured under hypoxia escape from senescence via downregulation of p16 and extracellular signal regulated kinase[J].Biochem Biophys Res Commun, 2010, 391(3):1471-1476.

[60]

HU X, LIU L, WANG Y. Human umbilical cord-derived mesenchymal stem cells alleviate acute lung injury caused by severe burn via secreting tsg-6 and inhibiting inflammatory response[J].Stem Cells Int, 2022, 2022:8661689.

[61]

DI G, DU X, QI X. Mesenchymal stem cells promote diabetic corneal epithelial wound healing through tsg-6-dependent stem cell activation and macrophage switch[J].Invest Ophthalmol Vis Sci, 2017, 58 (10): 4344-4354.

[62]

PAPAIT A,CANCEDDA R, MASTROGIACOMO M . Allogeneic platelet-rich plasma affects monocyte differentiation to dendritic cells causing an anti-inflammatory microenvironment, putatively fostering wound healing[J].J Tissue Eng Regen Med, 2018, 12(1):30-43.

[63]

RAHMAN S F. Synthesis of fibrin clot from fibrinogen platelet rich plasma (prp) for scaffold applications[J].Int J Eng Chem Biol Eng, 2023, 1(1):66-71.

[64]

SAHELI M, BAYAT M, GANJI R. Human mesenchymal stem cells-conditioned medium improves diabetic wound healing mainly through modulating fibroblast behaviors[J].Arch Dermatol Res, 2020, 312(5):325-336.

[65]

CHO J W, KIM S A, LEE K S. Platelet-rich plasma induces increased expression of G1 cell cycle regulators, type I collagen, and matrix metalloproteinase-1 in human skin fibroblasts[J].Int J Mol Med, 2012, 29(1):32-36.

[66]

NOVOSELETSKAYA E S,EVDOKIMOV P V,EFIMENKO A Y. Extracellular matrix-induced signaling pathways in mesenchymal stem/ stromal cells[J].Cell Commun Signal, 2023, 21(1):244.

[67]

SU W H, WANG C J,HUNG Y Y. MicroRNA-29a exhibited pro-angiogenic and anti-fibrotic features to intensify human umbilical cord mesenchymal stem cells-renovated perfusion recovery and preventing against fibrosis from skeletal muscle ischemic injury[J].Int J Mol Sci, 2019, 20(23):5859.

[68]

JI C, ZHANG J, ZHOU Z. Platelet-rich plasma promotes MSCs exosomes paracrine to repair acute kidney injury via AKT/ Rab27 pathway[J].Am J Transl Res, 2021, 13(3):1445-1457.

[69]

GRAFE I, ALEXANDER S, PETERSON J R. TGF-β family signaling in mesenchymal differentiation[J].Cold Spring Harb Perspect Biol, 2018, 10(5):a022202.

[70]

KELC R, TRAPECAR M, GRADISNIK L . Platelet-rich plasma, especially when combined with a TGF-β inhibitor promotes proliferation, viability and myogenic differentiation of myoblasts in vitro[J].PLoS One, 2015, 10(2):e0117302.

[71]

ULIVI V, TASSO R, CANCEDDA R. Mesenchymal stem cell paracrine activity is modulated by platelet lysate:induction of an inflammatory response and secretion of factors maintaining macrophages in a proinflammatory phenotype[J].Stem Cells Dev, 2014, 23 (16): 1858-1869.

[72]

FUKUI M, LAI F, HIHARA M. Activation of cell adhesion and migration is an early event of platelet-rich plasma (PRP)-dependent stimulation of human adipose-derived stem/ stromal cells[J].Hum Cell, 2024, 37(1):181-192.

[73]

KANG J, HUR J, KANG J A. Activated platelet supernatant can augment the angiogenic potential of human peripheral blood stem cells mobilized from bone marrow by G-CSF[J].J Mol Cell Cardiol, 2014, 75:64-75.

[74]

XU F T, LI H M, YIN Q S. Effect of activated autologous platelet-rich plasma on proliferation and osteogenic differentiation of human adipose-derived stem cells in vitro[J].Am J Transl Res, 2015, 7(2):257-270.

[75]

KURODA R, NIIKURA T, MATSUMOTO T. Phase III clinical trial of autologous CD34+ cell transplantation to accelerate fracture nonunion repair[J]. BMC Med, 2023, 21(1):386.

[76]

YIN N, WANG Y, DING L. Platelet-rich plasma enhances the repair capacity of muscle-derived mesenchymal stem cells to large humeral bone defect in rabbits[J].Sci Rep, 2020, 10(1):6771.

[77]

ASJID R, FAISAL T, QAMAR K. Platelet-rich Plasma-induced Inhibition of Chondrocyte Apoptosis Directly Affects Cartilage Thickness in Osteoarthritis[J].Cureus, 2019, 11(11):e6050.

[78]

HOPPER N, WARDALE J, BROOKS R. Peripheral blood mononuclear cells enhance cartilage repair in in vivo osteochondral defect model[J].PLoS One, 2015, 10(8):e0133937.

[79]

ZHANG K, XU T, XIE H. Donor-Matched peripheral blood-derived mesenchymal stem cells combined with platelet-rich plasma synergistically ameliorate surgery-induced osteoarthritis in rabbits: an in vitro and in vivo study[J].Am J Sports Med, 2023, 51 (11): 3008-3024.

[80]

KROCHMALSKI M, KILJANSKI M, KROCHMALSKI J. Intra-articular administration of pbhscs CD34+ as an effective modality of treatment and improving the quality of life in patients with coxarthrosis[J].J Clin Med, 2025, 14(8):2656.

[81]

TEI K, MATSUMOTO T,MIFUNE Y. Administrations of peripheral blood CD34-positive cells contribute to medial collateral ligament healing via vasculogenesis[J].Stem Cells, 2008, 26(3):819-830.

[82]

SCULLY D, SFYRI P, VERPOORTEN S. Platelet releasate promotes skeletal myogenesis by increasing muscle stem cell commitment to differentiation and accelerates muscle regeneration following acute injury[J].Acta Physiol (Oxf), 2019, 225(3):e13207.

[83]

TESTA S, RIERA C S, FORNETTI E. Skeletal muscle-derived human mesenchymal stem cells:influence of different culture conditions on proliferative and myogenic capabilities[J].Front Physiol, 2020, 11:553198.

[84]

MENCHISHEVA Y, MIRZAKULOVA U, YUI R. Use of platelet-rich plasma to facilitate wound healing[J].Int Wound J, 2019, 16(2):343-353.

[85]

TANAKA R, MASUDA H, KATO S. Autologous G-CSF-mobilized peripheral blood CD34+ cell therapy for diabetic patients with chronic nonhealing ulcer[J].Cell Transplant, 2014, 23(2):167-179.

[86]

HERSANT B, SID-AHMED M, BRAUD L. Platelet-rich plasma improves the wound healing potential of mesenchymal stem cells through paracrine and metabolism alterations[J].Stem Cells Int, 2019, 2019:1234263.

[87]

ZHANG C, ZHU Y, LU S. Platelet-rich plasma with endothelial progenitor cells accelerates diabetic wound healing in rats by upregulating the notch1 signaling pathway[J].J Diabetes Res, 2019, 2019:5920676.

[88]

EBRAHIM N, DESSOUKY A A,MOSTAFA O. Adipose mesenchymal stem cells combined with platelet-rich plasma accelerate diabetic wound healing by modulating the Notch pathway[J].Stem Cell Res Ther, 2021, 12(1):392.

[89]

TAMMAM B M H,HABOTTA O A,EL-KHADRAGY M. Therapeutic role of mesenchymal stem cells and platelet-rich plasma on skin burn healing and rejuvenation:A focus on scar regulation, oxido-inflammatory stress and apoptotic mechanisms[J].Heliyon, 2023, 9(9):e19452.

[90]

ZHENG C,ZHU Q,LIU X. Effect of platelet-rich plasma (PRP) concentration on proliferation, neurotrophic function and migration of Schwann cells in vitro[J].J Tissue Eng Regen Med, 2016, 10(5):428-436.

[91]

KHALED M M, IBRAHIUM A M, ABDELGALIL A I . Efficacy of using adipose-derived stem cells and PRP on regeneration of 40-mm long sciatic nerve defect bridged by polyglycolic-polypropylene mesh in canine model[J].Stem Cell Res Ther, 2024, 15(1):212.

[92]

CHO H H, JANG S, LEE S C. Effect of neural-induced mesenchymal stem cells and platelet-rich plasma on facial nerve regeneration in an acute nerve injury model[J].Laryngoscope, 2010, 120(5):907-913.

[93]

AMIN I, GELLHORN A C. Platelet-rich plasma use in musculoskeletal disorders: are the factors important in standardization well understood?[J].Phys Med Rehabil Clin N Am, 2019, 30(2):439-449.

[94]

WALLIS W D, QAZILBASH M H. Peripheral blood stem cell mobilization in multiple myeloma:Growth factors or chemotherapy?[J].World J Transplant, 2017, 7(5):250-259.

[95]

WANG K, LI Z, LI J. Optimization of the platelet-rich plasma concentration for mesenchymal stem cell applications[J].Tissue Eng Part A, 2019, 25(5-6):333-351.

[96]

LEMOLI R M. New strategies for stem cell mobilization[J].Mediterr J Hematol Infect Dis, 2012, 4 (1): e2012066.

[97]

ARITA A, TOBITA M. Adverse events related to platelet-rich plasma therapy and future issues to be resolved[J].Regen Ther, 2024, 26:496-501.

[98]

MAYOLY A, INIESTA A, CURVALE C. Development of autologous platelet-rich plasma mixed-microfat as an advanced therapy medicinal product for intra-articular injection of radio-carpal osteoarthritis:from validation data to preliminary clinical results[J].Int J Mol Sci, 2019, 20(5):1111.

[99]

RUSCONI G, CUSUMANO G, MARIOTTA L. Upgrading monocytes therapy for critical limb ischemia patient treatment:pre-clinical and gmp-validation aspects[J].Int J Mol Sci, 2022, 23(20):12669.

AI Summary AI Mindmap
PDF (1250KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉